Small dense LDL particles - a predictor of coronary artery disease evaluated by invasive and CT-based techniques: a case-control study

Lipids in Health and Disease - Tập 10 - Trang 1-7 - 2011
Anne P Toft-Petersen1, Hans H Tilsted1, Jens Aarøe1, Klaus Rasmussen1, Thorkil Christensen2, Bruce A Griffin3, Inge V Aardestrup1, Annette Andreasen1, Erik B Schmidt1
1Department of Cardiology, Center for Cardiovascular Research, Aalborg Hospital, Aarhus University Hospital, Aalborg, Denmark
2Department of Radiology, Center for Cardiovascular Research, Aalborg Hospital, Aarhus University Hospital, Aalborg, Denmark
3Faculty of Health & Medical Sciences, University of Surrey, Guildford, Surrey, UK

Tóm tắt

Coronary angiography is the current standard method to evaluate coronary atherosclerosis in patients with suspected angina pectoris, but non-invasive CT scanning of the coronaries are increasingly used for the same purpose. Low-density lipoprotein (LDL) cholesterol and other lipid and lipoprotein variables are major risk factors for coronary artery disease. Small dense LDL particles may be of particular importance, but clinical studies evaluating their predictive value for coronary atherosclerosis are few. We performed a study of 194 consecutive patients with chest pain, a priori considered of low to intermediate risk for significant coronary stenosis (>50% lumen obstruction) who were referred for elective coronary angiography. Plasma lipids and lipoproteins were measured including the subtype pattern of LDL particles, and all patients were examined by coronary CT scanning before coronary angiography. The proportion of small dense LDL was a strong univariate predictor of significant coronary artery stenosis evaluated by both methods. After adjustment for age, gender, smoking, and waist circumference only results obtained by traditional coronary angiography remained statistically significant. Small dense LDL particles may add to risk stratification of patients with suspected angina pectoris.

Tài liệu tham khảo

American Heart Association: Heart attack and angina statistics. 2010, http://www.americanheart.org/presenter.jhtml?identifier=4591 Greenland P, LaBree L, Azen SP, Doherty TM, Detrano RC: Coronary artery calcium score combined with Framingham score for risk prediction in asymptomatic individuals. JAMA. 2004, 291: 210-5. 10.1001/jama.291.2.210 Mowatt G, Cummins E, Waugh N, Walker S, Cook J, Jia X, Hillis GS, Fraser C: Systematic review of the clinical effectiveness and cost-effectiveness of 64-slice or higher computed tomography angiography as an alternative to invasive coronary angiography in the investigation of coronary artery disease. Health Technol Assess. 2008, 12: iii-143. Wilson PWF, D'Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB: Prediction of Coronary Heart Disease Using Risk Factor Categories. Circulation. 1998, 97: 1837-47. Tabas I, Williams KJ, Borén J: Subendothelial lipoprotein retention as the initiating process in atherosclerosis: update and therapeutic implications. Circulation. 2007, 116: 1832-44. 10.1161/CIRCULATIONAHA.106.676890 Nordestgaard BG, Benn M, Schnohr P, Tybjaerg-Hansen A: Nonfasting Triglycerides and Risk of Myocardial Infarction, Ischemic Heart Disease, and Death in Men and Women. JAMA. 2007, 298: 299-308. 10.1001/jama.298.3.299 Austin MA, King MC, Vranizan KM, Krauss RM: Atherogenic lipoprotein phenotype. A proposed genetic marker for coronary heart disease risk. Circulation. 1990, 82: 495-506. de Graaf J, Hak-Lemmers HL, Hectors MP, Demacker PN, Hendriks JC, Stalenhoef AF: Enhanced susceptibility to in vitro oxidation of the dense low density lipoprotein subfraction in healthy subjects. Arterioscler Thromb. 1991, 11: 298-306. Chancharme L, Therond P, Nigon F, Lepage S, Couturier M, Chapman MJ: Cholesteryl ester hydroperoxide lability is a key feature of the oxidative susceptibility of small, dense LDL. Arterioscler Thromb Vasc Biol. 1999, 19: 810-20. Ip S, Lichtenstein AH, Chung M, Lau J, Balk EM: Systematic review: association of low-density lipoprotein subfractions with cardiovascular outcomes. Ann Intern Med. 2009, 150: 474-84. Berneis KK, Krauss RM: Metabolic origins and clinical significance of LDL heterogeneity. J Lipid Res. 2002, 43: 1363-79. 10.1194/jlr.R200004-JLR200 Davies IG, Graham JM, Griffin BA: Rapid separation of LDL subclasses by iodixanol gradient ultracentrifugation. Clin Chem. 2003, 49: 1865-72. 10.1373/clinchem.2003.023366 Griffin BA, Minihane AM, Furlonger N, Chapman C, Murphy M, Williams D, Wright JJ, Williams CM: Inter-relationships between small, dense low-density lipoprotein (LDL), plasma triacylglycerol and LDL apoprotein B in an atherogenic lipoprotein phenotype in free-living subjects. Clin Sci (Lond). 1999, 97: 269-76. 10.1042/CS19990056 Rasmussen JG, Eschen RB, Aardestrup IV, Dethlefsen C, Griffin BA, Schmidt EB: Flow-mediated vasodilation: variation and interrelationships with plasma lipids and lipoproteins. Scand J Clin Lab Invest. 2009, 69: 156-60. 10.1080/00365510802460474 Achenbach S, Cardiac CT: state of the art for the detection of coronary arterial stenosis. J Cardiovasc Comput Tomogr. 2007, 1: 3-20. 10.1016/j.jcct.2007.04.007 St-Pierre AC, Cantin B, Dagenais GR, Mauriege P, Bernard PM, Despres JP, Lamarche B: Low-density lipoprotein subfractions and the long-term risk of ischemic heart disease in men: 13-year follow-up data from the Quebec Cardiovascular Study. Arterioscler Thromb Vasc Biol. 2005, 25: 553-9. 10.1161/01.ATV.0000154144.73236.f4 Arsenault BJ, Lemieux I, Despres JP, Wareham NJ, Luben R, Kastelein JJ, Khaw KT, Boekholdt SM: Cholesterol levels in small LDL particles predict the risk of coronary heart disease in the EPIC-Norfolk prospective population study. Eur Heart J. 2007, 28: 2770-7. 10.1093/eurheartj/ehm390 El Harchaoui KF, van der Steeg WA, Stroes ES, Kuivenhoven JA, Otvos JD, Wareham NJ, Hutten BA, Kastelein JJ, Khaw KT, Boekholdt SM: Value of low-density lipoprotein particle number and size as predictors of coronary artery disease in apparently healthy men and women: the EPIC-Norfolk Prospective Population Study. J Am Coll Cardiol. 2007, 49: 547-53. 10.1016/j.jacc.2006.09.043 Austin MA: Low-density lipoprotein particle size, triglycerides, and high-density lipoprotein cholesterol as risk factors for coronary heart disease in older Japanese-American men. Am J Cardiol. 2000, 86: 412-6. 10.1016/S0002-9149(00)00956-5 Blake GJ, Otvos JD, Rifai N, Ridker PM: Low-density lipoprotein particle concentration and size as determined by nuclear magnetic resonance spectroscopy as predictors of cardiovascular disease in women. Circulation. 2002, 106: 1930-7. 10.1161/01.CIR.0000033222.75187.B9 Koba S, Hirano T, Ito Y, Tsunoda F, Yokota Y, Ban Y, Iso Y, Suzuki H, Katagiri T: Significance of small dense low-density lipoprotein-cholesterol concentrations in relation to the severity of coronary heart diseases. Atherosclerosis. 2006, 189: 206-14. 10.1016/j.atherosclerosis.2005.12.002 Kwon SW, Yoon SJ, Kang TS, Kwon HM, Kim JH, Rhee J, Lee SJ, Park JK, Lim JY, Yoon YW, Hong BK: Significance of small dense low-density lipoprotein as a risk factor for coronary artery disease and acute coronary syndrome. Yonsei Med J. 2006, 47: 405-14. 10.3349/ymj.2006.47.3.405 Chung M, Lichtenstein AH, Ip S, Lau J, Balk EM: Comparability of methods for LDL subfraction determination: A systematic review. Atherosclerosis. 2009, 205: 342-8. 10.1016/j.atherosclerosis.2008.12.011 Koz C, Baysan O, Hasimi A, Cihan M, Uzun M, Yokusoglu M, Sag C, Isik E: Conventional and non-conventional coronary risk factors in male premature coronary artery disease patients already having a low Framingham risk score. Acta Cardiol. 2008, 63: 623-8. 10.2143/AC.63.5.2033231 Backes JM, Gibson CA: Effect of lipid-lowering drug therapy on small-dense low-density lipoprotein. Ann Pharmacother. 2005, 39: 523-6. 10.1345/aph.1E322